FLT3-IN-4,2304799-09-3

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

FLT3-IN-4

CAS No. : 2304799-09-3

MCE 国际站：FLT3-IN-4

产品活性：FLT3-IN-4 是一种口服有效的 Fms 样酪氨酸受体激酶 3 (FLT3; IC₅₀= 7 nM) 抑制剂，可用于急性髓性白血病的研究。

研究领域：Protein Tyrosine Kinase/RTK

作用靶点：FLT3

In Vitro: FLT3-IN-4 (Compound 9u) shows potent inhibitory activities against MV4-11 and Molm-13 cells with IC₅₀ values are 0.089±0.001 nM and 0.022±0.003 nM, respectively.

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  Protein Tyrosine Kinase Compound Library  |  Anti-Cancer Compound Library  |  Covalent Screening Library  |  Anti-Blood Cancer Compound Library  |  Membrane Protein-targeted Compound Library  |  Cytokine Inhibitors Library  |  Sorafenib  |  Cabozantinib  |  Gilteritinib  |  Quizartinib  |  Pacritinib  |  Crenolanib  |  Fostamatinib  |  R406  |  Linifanib  |  Emavusertib  |  Rebastinib  |  Ripretinib  |  AT9283  |  Dovitinib  |  KW-2449  |  Sitravatinib  |  (E/Z)-Zotiraciclib  |  UNC2025  |  Gandotinib  |  Merestinib  |  CHIR-124  |  TG101209  |  AST 487  |  Lestaurtinib  |  MRX-2843

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds